Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Rabies01:28

Rabies

Rabies is a lethal zoonotic disease caused by a single-stranded, negative-sense RNA virus of the Lyssavirus genus, within the family Rhabdoviridae. Its primary mode of transmission to humans is through bites or saliva-contaminated scratches from infected mammals such as dogs, bats, raccoons, or foxes. Transmission can also occur if infectious saliva contacts abraded skin or intact mucous membranes, including the conjunctiva.Viral Entry and Early ReplicationOnce introduced at the bite or scratch...
Rocky Mountain Spotted Fever01:26

Rocky Mountain Spotted Fever

Rocky Mountain Spotted Fever (RMSF) is a severe tick-borne illness caused by Rickettsia rickettsii, a Gram-negative, coccobacillary bacterium. This pathogen is an obligate intracellular parasite, requiring a host cell for replication. Transmission occurs through the bite of an infected tick. In the United States, the most important vectors are Dermacentor variabilis (American dog tick) and Dermacentor andersoni (Rocky Mountain wood tick), though other tick species may also serve as vectors.
Humoral Immune Responses01:36

Humoral Immune Responses

Overview

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Visual and infrared input to the same dendrite in the tectum opticum of the python, Python regius: electron-microscopic evidence.

Brain research·1992
Same author

Intracellular protons inhibit inward rectifier K+ channel of guinea-pig ventricular cell membrane.

Pflugers Archiv : European journal of physiology·1992
Same author

Isolation and characterization of type 1 fimbriae from a chicken pathogenic Escherichia coli serotype O78.

The Journal of veterinary medical science·1992
Same author

Characterization of YM060, a potent and selective 5-hydroxytryptamine3 receptor antagonist, in rabbit nodose ganglion and N1E-115 neuroblastoma cells.

The Journal of pharmacology and experimental therapeutics·1992
Same author

[Clinical study on the time courses of serum myosin light chain I levels in patients with acute myocardial infarction: effect of intracoronary thrombolysis on serum myosin light chain I levels].

Kaku igaku. The Japanese journal of nuclear medicine·1992
Same author

Frequent amplification of the c-met gene in scirrhous type stomach cancer.

Biochemical and biophysical research communications·1992

Related Experiment Video

Updated: Jun 19, 2026

Intratracheal Inoculation of Fischer 344 Rats with Francisella tularensis
06:09

Intratracheal Inoculation of Fischer 344 Rats with Francisella tularensis

Published on: September 30, 2017

CIRCULATING IMMUNITY PRINCIPLES IN RAT-BITE FEVER.

Y Ido1, H Ito, H Wani

  • 1First Medical Clinic of the Imperial University in Kyushu, Fukuoka, Japan.

The Journal of Experimental Medicine
|October 30, 2009
PubMed
Summary
This summary is machine-generated.

Rat-bite fever convalescent serum contains antibodies that destroy the disease-causing spirochetes. These antibodies demonstrated effectiveness in vitro and in vivo, offering potential therapeutic insights.

More Related Videos

Rat Model of Widespread Cerebral Cortical Demyelination Induced by an Intracerebral Injection of Pro-Inflammatory Cytokines
09:46

Rat Model of Widespread Cerebral Cortical Demyelination Induced by an Intracerebral Injection of Pro-Inflammatory Cytokines

Published on: September 21, 2021

Induction and Monitoring of Active Delayed Type Hypersensitivity (DTH) in Rats
13:26

Induction and Monitoring of Active Delayed Type Hypersensitivity (DTH) in Rats

Published on: July 19, 2007

Related Experiment Videos

Last Updated: Jun 19, 2026

Intratracheal Inoculation of Fischer 344 Rats with Francisella tularensis
06:09

Intratracheal Inoculation of Fischer 344 Rats with Francisella tularensis

Published on: September 30, 2017

Rat Model of Widespread Cerebral Cortical Demyelination Induced by an Intracerebral Injection of Pro-Inflammatory Cytokines
09:46

Rat Model of Widespread Cerebral Cortical Demyelination Induced by an Intracerebral Injection of Pro-Inflammatory Cytokines

Published on: September 21, 2021

Induction and Monitoring of Active Delayed Type Hypersensitivity (DTH) in Rats
13:26

Induction and Monitoring of Active Delayed Type Hypersensitivity (DTH) in Rats

Published on: July 19, 2007

Area of Science:

  • Immunology
  • Infectious Diseases
  • Microbiology

Background:

  • Rat-bite fever is caused by specific spirochetes.
  • Understanding the immune response to rat-bite fever is crucial for developing treatments.

Purpose of the Study:

  • To investigate the presence and efficacy of antibodies in the serum of rat-bite fever convalescents.
  • To determine the spirochetolytic and spirocheticidal properties of convalescent serum.

Main Methods:

  • Analysis of antibodies in convalescent rat-bite fever serum.
  • In vitro testing using hanging drop preparations.
  • In vivo studies in guinea pigs (Pfeiffer's test) and experimentally infected mice.

Main Results:

  • Convalescent serum demonstrated specific antibodies against the causative agent of rat-bite fever.
  • Serum effectively destroyed spirochetes in vitro and in the peritoneal cavity of guinea pigs.
  • Administration of convalescent serum to infected mice significantly reduced or eliminated spirochetes.

Conclusions:

  • The blood serum of rat-bite fever convalescents contains effective antibodies.
  • Antibody effectiveness persisted for extended periods post-recovery (up to 11 months observed).
  • Further research is needed to determine the long-term duration of antibody efficacy in humans.